ChromaDex (CDXC) 10-Q2012 Q1 Quarterly report

Filed: 10 May 12, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: accrued, added, agency, allocated, array, assigned, bear, behalf, binomial, biopharmaceutical, Boulder, buying, campaign, ceased, chain, characterized, classification, Colorado, commenced, commitment, committed, Committee, compensatory, composition, core, costly, ct, currency, Debra, deducting, deemed, default, denominated, distribution, duly, duration, EternalBlu, evidence, Exhibit, exposure, fall, February, FIFO, fixed, foreign, forfeited, forfeiture, FTC, health, HeartBlu, heavy, Heim, herewith, highly, Himmel, illiquidity, Incorporated, incorporation, inflation, ingredient, instability, insured, interactive, intersegment, Jeffrey, labeling, laboratory, Latin, lease, level, liability, liquid, Liquidity, located, media, MemoryBlu, negative, notification, November, online, OPKO, opportunity, part, payable, payroll, portfolio, president, produce, profile, proportion, pTeroPure, radio, range, registered, Release, reviewed, reviewing, safety, sale, scheduled, SEC, segment, Segmentation, segregating, sensitivity, Separation, serving, short, specific, spending, Spengler, state, stated, submitted, sudden, supply, television, thereunto, thinly, trade, traded, TrimBlu, typically, undersigned, unique, USDA, varvaro, William, working

Removed: accountable, acquire, advancing, arranging, began, bulk, burden, chemistry, commercialize, compliance, comprehensive, consummation, discovery, enforce, enforcement, enforcing, environmentally, experienced, functional, Good, green, heavily, higher, implemented, incur, incurring, innovative, interpretation, interpreted, invested, issuing, lack, large, manufacturing, marketplace, nutraceutical, operational, order, outcome, payment, personnel, profitability, proper, reduced, regulate, reliable, REMOVED, RESERVED, structure, team, testing, twelve, ultimately, utilize, violation, warning

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

CDXC similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

Certification Pursuant to 18 U.S.C. Section 1350

(as adopted pursuant to Section 906 of the Sarbanes−Oxley Act of 2002)

In connection with this quarterly report of ChromaDex Corporation (the “Company”) on Form 10−Q for the quarter ending March 31, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), we, Jeffrey Himmel, Chief Executive Officer of the Company, and Thomas C. Varvaro, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes−Oxley Act of 2002, that, to our knowledge:

1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: May 10, 2012

/s/ JEFFREY HIMMEL

Jeffrey Himmel

Chief Executive Officer

/s/ THOMAS C. VARVARO

Thomas C. Varvaro

Chief Financial Officer